Press ReleasesCannovum Launches Cannabis Medical Education Platform

Cannovum Launches Cannabis Medical Education Platform

-

CANNOVUM AG (stock exchanges Düsseldorf, Munich, Hamburg, Berlin, gettex: ISIN DE000A2LQU21) announces the launch of its Medical Education Platform (CME).

This is a free, comprehensive virtual continuing education platform for medical cannabis, in which the medical-therapeutic basics of medical cannabis are scientifically prepared.

The continuing education offer consists of four different areas:

1.) CANNOVUM Online Seminars: on-demand video courses with experts, which are regularly expanded to include current topics

2.) CANNOVUM Workshops: individually designed workshops for healthcare professionals

3.) CANNOVUM Study Material: brochures and information material for self-study

4.) CANNOVUM Literature: a literature service with current literature collections and regular study summaries


Cannabis and its effects in the body are still rarely part of medical or pharmaceutical education. Physicians, pharmacists, and healthcare professionals must therefore acquire the knowledge through continuing education.

“We created Cannovum Medical Education because the topic of cannabis is unfortunately still very stigmatized socially and many patients who could be helped by cannabis therapy do not have access to it. With further education about the medical potential of cannabis, we can reduce reservations and provide a broader understanding of this form of therapy. In this way, we can support doctors, pharmacists and healthcare professionals in particular to improve patient care and provide the best therapy for each patient,” says Pia Marten, CEO of Cannovum AG.

The individual courses are led by Cannovum’s Medical Advisory Board: Dr. med. Dipl.-Chem. Konrad F. Cimander, a renowned expert in the field of addiction medicine and cannabis therapy and Chief Medical Advisor at Cannovum, Priv. Doz. Dr. med. habil. Philipp Sewerin, private lecturer and specialist in internal medicine and rheumatology, and Dr. Sandra Bütow, Head of Medical Affairs at Cannovum.

Cannovum Medical Education combines scientifically sound expertise with the wealth of knowledge gained from many years of experience with cannabis-based therapies in order to optimally support healthcare professionals in the care of patients.

Latest news

Akanda Pulls Out Of Lesotho Amid Ongoing Legal Battle, Bruce Linton Joins SynBiotic, & Ananda Completes Acquisition

Akanda The NASDAQ-listed international medical cannabis operator announced last week that it will abandon its operations in Lesotho following...

Concerns Grow As Cannabis Sceptic Appointed To Lead Malta’s Adult-Use Reform

ALMOST one year since passing legislation fears are growing the Maltese Government is set to undermine its commitment to...

Brains Bio Receives NSF’s First CBD Certification For EU GMP CBD API

PRESS RELEASE BRAINS Bioceutical Corp ("Brains Bio" or the "Company"), a global leader in EU GMP grade Cannabidiol (CBD) has...

Amsterdam Cannabis Expo 2022 Latest Scam To Target Industry

AN upcoming European cannabis conference, at which 10,000 cannabis companies were purportedly due to visit, is thought to be...

Juicy Fields Scam May Have Been Small Part Of A Much Larger Criminal Enterprise Says Lawyer As He Prepares To Make Evidence Public

JUICY Fields has already been called the biggest scam in Europe for ‘many, many years’, and its impact on...

Seizure Of 32 Tons Of Cannabis In Spain Was Actually Hemp

BETWEEN telephone calls, Francisco Carbó continues finalising contracts for E-Canna, the hemp processing company he owns based in Valencia,...

Must read

Akanda Pulls Out Of Lesotho Amid Ongoing Legal Battle, Bruce Linton Joins SynBiotic, & Ananda Completes Acquisition

Akanda The NASDAQ-listed international medical cannabis operator announced last...

Concerns Grow As Cannabis Sceptic Appointed To Lead Malta’s Adult-Use Reform

ALMOST one year since passing legislation fears are growing...

You might also likeRELATED
Recommended to you